Back

Antibody boosting and short-term durability following SARS-CoV-2 infections in United States longitudinal cohorts, 2020-2024

Yang, Y.; Risukhina, A.; Callear, A.; Juntila-Raymond, C.; Johnson, E.; Godonou, E.-T.; Smith, M.; Midgley, C. M.; Jones, J. M.; Monto, A. S.; Martin, E. T.

2026-09-20 epidemiology
10.64898/2026.09.17.26363304 medRxiv
Show abstract

To characterize anti-nucleocapsid (anti-N) IgG binding antibody responses following first PCR-confirmed SARS-CoV-2 infections in a highly vaccinated population, we evaluated antibody boosting and durability in a longitudinal cohort in Michigan. Among 113 participants with paired pre- and post-infection serum specimens tested using a multiplex electrochemiluminescence assay, SARS-CoV-2 infection induced substantial boosting of anti-N IgG concentrations; approximately 80% of participants becoming anti-N seropositive following infection, and 81% of participants demonstrating at least a 4-fold rise in antibody concentrations following infection. Population-level analyses of 66 participants with post-infection serum specimens collected 52-120 days after infection demonstrated sustained anti-N IgG concentrations over time, with no evidence of substantial decline. These findings demonstrate robust boosting and sustained infection-induced anti-N IgG responses in a highly vaccinated population through four months following SARS-CoV-2 infection. This supports the use of anti-N antibodies for longitudinal serosurveillance, including those who are vaccinated.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.